Condensed Interim Consolidated Statements of Earnings (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Condensed Interim Consolidated Statements of Earnings (Unaudited) | ||||
| Revenue | $ 17,715 | $ 17,133 | $ 51,318 | $ 43,320 |
| Direct manufacturing costs | 11,527 | 11,856 | 33,977 | 29,962 |
| Gross margin | 6,188 | 5,277 | 17,341 | 13,358 |
| Expenses | ||||
| Research and development | (407) | 1,169 | 2,294 | 3,223 |
| Government assistance | 737 | (1) | (94) | (85) |
| Sales and marketing | 715 | 582 | 2,540 | 1,866 |
| General and administrative | 1,474 | 634 | 4,115 | 2,907 |
| Stock based compensation | 2,382 | 543 | 2,781 | 1,246 |
| Depreciation and amortization | 499 | 388 | 1,362 | 1,033 |
| Total operating expenses | 5,400 | 3,315 | 12,998 | 10,190 |
| Income from operations | 788 | 1,962 | 4,343 | 3,168 |
| Net finance charges | 384 | 591 | 1,376 | 1,925 |
| Foreign exchange loss (gain) and interest income | 99 | 464 | 704 | (72) |
| Income tax recovery | 0 | 0 | 99 | 0 |
| Net income for the period | $ 305 | $ 907 | $ 2,362 | $ 1,315 |
| Basic income per share | $ 0.01 | $ 0.02 | $ 0.05 | $ 0.04 |
| Diluted income per share | $ 0.01 | $ 0.02 | $ 0.05 | $ 0.03 |
| Weighted average number of shares - basic | 49,744,052 | 40,100,715 | 48,200,156 | 37,509,735 |
| Weighted average number of shares - diluted | 52,497,545 | 42,011,683 | 50,378,421 | 40,234,391 |
| X | ||||||||||
- Definition The element represents direct manufacturing costs. No definition available.
|
| X | ||||||||||
- Definition The element represents stock based compensation. No definition available.
|
| X | ||||||||||
- Definition The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The gross gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of all operating expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income recognised in relation to government grants. [Refer: Government grants] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense relating to the marketing and selling of goods or services. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|